Earnings summaries and quarterly performance for SCOTTS MIRACLE-GRO.
Research analysts who have asked questions during SCOTTS MIRACLE-GRO earnings calls.
Eric Bosshard
Cleveland Research Company
4 questions for SMG
Also covers: DHI, LOW, MHK +3 more
JA
Jon Andersen
William Blair & Company
4 questions for SMG
Also covers: BRBR, BRCC, CELH +11 more
Christopher Carey
Wells Fargo & Company
3 questions for SMG
Also covers: CAG, CHD, CL +21 more
JM
Jonathan Matuszewski
Jefferies Financial Group Inc.
2 questions for SMG
Also covers: ARHS, ASO, BBBY +11 more
JA
Joseph Altobello
Raymond James & Associates, Inc.
2 questions for SMG
Also covers: BC, BRCC, CWH +16 more
PG
Peter Grom
UBS Group
2 questions for SMG
Also covers: BRBR, CELH, CHD +25 more
WA
W. Andrew Carter
Stifel
2 questions for SMG
Also covers: ARHS, HAYW, HYFM +4 more
Martin Mitela
Raymond James & Associates, Inc.
1 question for SMG
Also covers: BRCC, GOLF, HLLY +3 more
WC
William Carter
Stifel Financial Corp
1 question for SMG
Also covers: HLMN
William Chappell
Truist Securities
1 question for SMG
Also covers: BRBR, BRCC, CENT +9 more
WR
William Reuter
Bank of America
1 question for SMG
Also covers: ACCO, ADV, ARKO +11 more
Recent press releases and 8-K filings for SMG.
ScottsMiracle-Gro CEO supports cannabis rescheduling order
SMG
New Projects/Investments
M&A
- Scotts Miracle-Gro (SMG) supports President Trump's executive order to reschedule cannabis from a Schedule I to a Schedule III drug, a move CEO Jim Hagedorn called "long overdue".
- The rescheduling will remove the 280E tax penalty for cannabis companies, which previously resulted in tax rates of 70% or higher, allowing them to shift financial resources into capital investment and growth opportunities.
- This change is expected to positively impact SMG's Hawthorne Gardening Company subsidiary, which provides supplies to legal cannabis operations, as increased capital spending by cannabis companies could follow.
- ScottsMiracle-Gro plans to combine Hawthorne with a cannabis company early in fiscal 2026 as part of its strategy to focus Hawthorne as a cannabis-dedicated entity, with the reclassification making it a more attractive partner.
Dec 18, 2025, 7:46 PM
Scotts Miracle-Gro Outlines Growth and Margin Recovery Strategy
SMG
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
M&A
- Scotts Miracle-Gro's U.S. consumer business experienced volatility in fiscal years 2024 and 2025, with a combined cumulative growth of 6%-7% over those two years, averaging 3%-3.5% annually. The company projects at least 3% annual sales growth moving forward, with retailer inventories now healthy.
- The company aims to restore gross margins to 35% or higher, having reached 31% at the end of 2025 and guiding to 32%, through a strategy focusing on 1% annual pricing and 1% annual cost savings.
- Growth will be fueled by mid-single digit branded growth in 2026, a shift away from low-margin commodity products, and double-digit e-commerce growth which currently accounts for 10% of POS sales.
- SMG gained four points of market share in fiscal year 2024 and plans for small, EPS-accretive tuck-in acquisitions under $100 million.
Dec 9, 2025, 7:20 PM
Scotts Miracle-Gro Outlines U.S. Consumer Business Growth and Gross Margin Recovery Strategy
SMG
Guidance Update
New Projects/Investments
M&A
- Scotts Miracle-Gro (SMG) anticipates annual sales growth of at least 3% for its U.S. consumer business, projecting 1% annual pricing and 2% volume growth driven by innovation and e-commerce.
- The company aims to increase gross margins from 31% at the end of fiscal 2025 (guided to 32%) back to the mid-30s, through annual pricing, cost savings, and investments in automation and robotics.
- E-commerce sales currently account for approximately 10% of POS sales and are experiencing double-digit growth, with Amazon representing about half of these online sales.
- SMG gained four points of market share in fiscal year 2024 and is strategically shifting focus from low-margin commodity products to higher-margin branded offerings.
Dec 9, 2025, 7:20 PM
Scotts Miracle-Gro Discusses U.S. Consumer Business, Gross Margin Recovery, and Growth Strategies
SMG
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
- Scotts Miracle-Gro (SMG) reported its U.S. consumer business achieved a combined cumulative sales growth of 6%-7% over fiscal 2024 and 2025, averaging 3%-3.5% annually, with retailer inventories now healthy. The company aims for at least 3% annual sales growth, driven by innovation, retailer partnerships, pricing, and E-commerce.
- The company is targeting a return to 35% gross margin or higher, up from 31% at the end of 2025 and a guided 32% for 2026. This improvement is expected through 1% annual pricing, 1% annual cost savings from supply chain efficiencies and automation, and innovation.
- E-commerce sales now represent about 10% of SMG's POS sales, growing at double digits, with Amazon accounting for approximately half of online sales. The company is also shifting focus from low-margin commodity products to branded products, anticipating mid-single digit branded growth in 2026.
- SMG gained four points of market share in fiscal 2024, netting a point this year, while private label market share remained flat at about 15%. Future growth plans include tuck-in acquisitions of $100 million or less that are EPS accretive and leverage neutral.
Dec 9, 2025, 7:20 PM
Scotts Miracle-Gro Reports Strong Q4 2025 Results and Issues Positive FY26 Guidance
SMG
Earnings
Guidance Update
Share Buyback
- Scotts Miracle-Gro (SMG) reported strong fiscal year 2025 results, with non-GAAP adjusted earnings per diluted share of $3.74 and adjusted EBITDA of $581 million, exceeding guidance. The company also generated $274 million in free cash flow, reducing its net debt to adjusted EBITDA leverage ratio to 4.1x.
- For fiscal year 2026, SMG expects low single-digit growth in U.S. Consumer net sales, a non-GAAP adjusted gross margin rate of at least 32%, and non-GAAP adjusted earnings per share between $4.15 and $4.35. The company anticipates mid-single digit growth in adjusted EBITDA, $275 million in free cash flow, and a leverage ratio in the high 3x range.
- The company plans to implement a multiyear share buyback program in fiscal year 2026, with a potential size of $500 million to $1 billion, and expects to close a new credit facility on better terms later in November.
- Strategic initiatives include a shift towards higher-margin branded products by de-emphasizing commodities, significant e-commerce expansion with over a 50% increase in POS units in FY25, and continued focus on supply chain savings, having achieved over $100 million in FY25.
Nov 5, 2025, 2:00 PM
Scotts Miracle-Gro Reports Q4 and Full Year 2025 Results and Provides Fiscal 2026 Guidance
SMG
Earnings
Guidance Update
- Scotts Miracle-Gro met or exceeded all financial guidance for fiscal year 2025.
- For fiscal year 2025, Non-GAAP adjusted EBITDA grew 14% to $581 million and Non-GAAP adjusted EPS increased 63% to $3.74 per share. The company also generated $274 million in free cash flow and reduced debt by $120 million, lowering the leverage ratio to 4.1x.
- The company provided fiscal year 2026 guidance, projecting Adjusted EPS between $4.15 and $4.35 per share, an Adjusted Gross Margin Rate of at least 32%, and mid single-digit growth in Adjusted EBITDA.
- Mid-range strategic goals (end of FY27) include 3 percent annual net sales growth, achieving a mid-30s percent gross margin rate, and a leverage ratio below 3.5x adjusted EBITDA.
Nov 5, 2025, 2:00 PM
Scotts Miracle-Gro Reports Strong Fiscal 2025 Results and Provides Fiscal 2026 Guidance
SMG
Earnings
Guidance Update
- Scotts Miracle-Gro reported strong fiscal 2025 full-year results, with non-GAAP adjusted earnings of $3.74 per share and non-GAAP Adjusted EBITDA of $581 million.
- The company achieved a non-GAAP adjusted gross margin rate of 31.2%, an improvement of 490 basis points over the prior year, and generated $274 million in free cash flow.
- For fiscal 2026, Scotts Miracle-Gro expects non-GAAP adjusted earnings per share of $4.15 to $4.35, a non-GAAP adjusted gross margin of at least 32%, and $275 million in free cash flow.
- The company also reduced its net leverage to 4.10x in fiscal 2025, an improvement of 0.76x versus last year, and aims to drive it down to the high 3s in fiscal 2026.
Nov 5, 2025, 12:36 PM
Scotts Miracle-Gro Outlines FY 2025 Financial Targets and Strategic Focus
SMG
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
- Scotts Miracle-Gro (SMG) is prioritizing its U.S. Consumer lawn and garden business, which represents 90% of its revenue and is expected to achieve low single-digit volume growth.
- The company targets a 30% total company gross margin rate for fiscal year 2025, with a goal to reach the mid-30% range over the subsequent two years, supported by $75 million in cost reductions for FY 2025 and a three-year target of $150 million.
- SMG anticipates generating $250 million in free cash flow for fiscal year 2025, following $1 billion generated in fiscal 2023 and 2024.
- The Hawthorne Gardening segment, with sales stabilized at $250 million to $300 million, is being prepared for an exit, likely as an investment rather than a cash sale, and is expected to contribute $20 million of EBITDA to the overall guidance of $570 million-$590 million for FY 2025.
Mar 4, 2025, 7:50 PM
Scotts Miracle-Gro Outlines FY 2025 Financial Targets and Hawthorne Exit Strategy
SMG
Guidance Update
New Projects/Investments
M&A
- Scotts Miracle-Gro (SMG) targets a 30% total company gross margin rate for fiscal year 2025, aiming for mid-30s in the subsequent two years, and projects $570-$590 million in EBITDA for FY 2025.
- The company plans to achieve 3% overall sales growth in FY 2025, comprising 2% volume growth and 1% pricing, with the U.S. consumer lawn and garden business expected to grow in the low single digits.
- SMG is actively pursuing an exit strategy for its Hawthorne Gardening segment and Hawthorne Collective investment portfolio within FY 2025, with Hawthorne projected to contribute $20 million in EBITDA for the year.
- Strategic initiatives include $75 million in cost reductions for FY 2025 (part of a $150 million three-year target) and reinvestment into key areas like advertising (targeting over $200 million long-term) and R&D (over $35 million).
Mar 4, 2025, 7:50 PM
Quarterly earnings call transcripts for SCOTTS MIRACLE-GRO.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more